Frequency Electronics reported earnings of 34 cents per share for the fourth quarter, up from 28 cents per share in the ...

Astellas Pharma recently announced that it had entered into an agreement with Frequency Therapeutics to co-develop and commercialise FX-322, a regenerative therapy to treat hearing loss.

Korro Bio plans a reverse merger with Frequency Therapeutics to fund clinical studies of its lead candidate, designed to treat alpha-1 antitrypsin deficiency (AATD) in the liver.

Korro Bio Inc and Frequency Therapeutics Inc FREQ announced an all- stock merger transaction. Under the merger agreement's terms, stockholders of Korro Bio will receive newly issued shares of ...

Frequency Therapeutics announced it will scrap development of a drug called FX-322 after testing failed to show improvement in speech perception in people with noise-induced sensorineural hearing ...

Frequency Therapeutics said its hearing loss drug candidate failed to beat a placebo in its second mid-stage clinical trial. The biotech is now focusing its regenerative medicine platform on the ...

Frequency Therapeutics, Inc. (FREQ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

What Is Frequency Therapeutics's Debt? The image below, which you can click on for greater detail, shows that at September 2021 Frequency Therapeutics had debt of US$15.0m, up from none in one year.

Frequency Therapeutics redesigns study after disappointing Phase 2 results, debuts new hearing loss and MS drugs Emma Betuel 7:19 AM PST · November 9, 2021 ...

NEW YORK, July 1, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FREQ) and ...

Frequency Therapeutics is going back to the drawing board. After showing promise in phase 1, four dosing regimens of its hearing loss treatment did no better than placebo in a phase 2a study. The ...